Literatur
Robert-Koch-Institut, Zentrum für Krebsregisterdaten, 2018; https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Prostatakrebs/prostatakrebs.html; abgerufen am 7.1.2020
Reeve BB et al. Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst. 2009; 101: 860-8
Dahl AA et al. Quality of life in survivors of testicular cancer. Urol Oncol. 2005; 23: 193-200
Prabhu V et al. Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer. Rev Urol. 2013; 15: 161-77
Lardas M et al. Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review. Eur Urol. 2017; 72: 869-85
Chambers SK et al. Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancer. Psychooncology. 2017; 26: 1576-85
Bloch S et al. Psychological adjustment of men with prostate cancer: a review of the literature. Biopsychosoc Med. 2007; 1: 2
Chambers SK et al. Intervening to improve psychological outcomes for men with prostate cancer. Psychooncology. 2013; 22: 1025-34
Epstein RM et al. in: Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing Suffering. Bethesda: National Cancer Institute; 2007
Bundesgesundheitsministerium. Nationaler Krebsplan. 2008; https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/N/Nationaler_Krebsplan/Nationaler_Krebsplan-Zieluebersicht.pdf; abgerufen am 7.1.2020
Sinfield P et al. Men's and carers' experiences of care for prostate cancer: a narrative literature review. Health Expect. 2009; 12: 301-12
Wittmann D et al. Patient preoperative expectations of urinary, bowel, hormonal and sexual functioning do not match actual outcomes 1 year after radical prostatectomy. J Urol. 2011; 186: 494-9
Steginga SK et al. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Urology. 2004; 63: 751-6
Diefenbach MA et al. Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer Invest. 2007; 25: 449-57
Stalmeier PF et al. Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy. J Clin Oncol. 2007; 25: 3096-100
Tariman JD et al. Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review. Ann Oncol. 2010; 21: 1145-51
Elwyn G et al. A three-talk model for shared decision making: multistage consultation process. BMJ. 2017; 359: j4891
Ernstmann N et al. (2019). Prostate-specific health-related quality of life and patient-physician communication - a 3.5-year follow-up. Patient Educ Couns. 2019; 102: 2114-21
Martínez-González NA et al. Shared decision making for men facing prostate cancer treatment: a systematic review of randomized controlled trials. Patient Prefer Adherence. 2019; 13: 1153-74
Groeben C et al. Treatment of nonmetastatic prostate cancer: a systematic review of interactive, personalized patient decision aids. Der Urologe. 2014; 53: 854-64
Violette PD et al. Decision aids for localized prostate cancer treatment choice: systematic review and meta-analysis. CA Cancer J Clin. 2015; 65: 239-51
Carlson LE et al. What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period. Psychooncology. 2013; 22: 168-76
Mehnert A et al. One in two cancer patients is significantly distressed: Prevalence and indicators of distress. Psychooncology. 2018; 27: 75-82
Mehnert A et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014, 32(31), 3540-6
Baumeister H et al. Auswirkungen komorbider psychischer Störungen bei chronischen körperlichen Erkrankungen. Zeitschrift für medizinische Psychologie. 2005; 14: 175-89
Bhanvadia SK. Bladder Cancer Survivorship. Curr Urol Rep. 2018; 19: 111
Carlsson S et al. Risk of suicide in men with low-risk prostate cancer. Eur J Cancer. 2013; 49: 1588-99
Ernstmann N et al Determinants and implications of cancer patients' psychosocial needs. Support Care Cancer. 2009; 17: 1417-23
Grassi L et al. Advancing psychosocial care in cancer patients. F1000Res. 2017; 6: 2083
Dahl AA et al. Quality of life in survivors of testicular cancer. Urol Oncol. 2005; 23: 193-200
Mehnert A et al. Die deutsche Version des NCCN Distress-Thermometers: Empirische Prüfung eines Screening-instruments zur Erfassung psychosozialer Belastung bei Krebspatienten. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie. 2006; 54: 213-23
Chambers SK et al. The validity of the distress thermometer in prostate cancer populations. Psychooncology. 2014; 23: 195-203
Parahoo K et al. Psychosocial interventions for men with prostate cancer: a Cochrane systematic review. BJU Int. 2015; 116: 174-83
Chambers SK et al. A systematic review of psychosocial interventions for men with prostate cancer and their partners. Patient Educ Couns. 2011; 85: e75-88
Hoey LM et al. Systematic review of peer-support programs for people with cancer. Patient Educ Couns. 2008; 70: 315-37
King AJ et al. Prostate cancer and supportive care: a systematic review and qualitative synthesis of men's experiences and unmet needs. Eur J Cancer Care (Engl). 2015; 24: 618-34
Scheffold K et al. Efficacy of a brief manualized intervention Managing Cancer and Living Meaningfully (CALM) adapted to German cancer care settings: study protocol for a randomized controlled trial. BMC Cancer. 2015; 15: 592
Faller H et al. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013; 31: 782-93
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Die Autoren erklären, dass er sich bei der Erstellung des Beitrags von keinen wirtschaftlichen Interessen leiten ließen und dass keine potenziellen Interessenkonflikte vorliegen.
Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.
Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind
Rights and permissions
About this article
Cite this article
Karger, A., Fugmann, D. & Ernstmann, N. Bedeutung von Kommunikation und psychoonkologischen Hilfen. Uro-News 24, 38–45 (2020). https://doi.org/10.1007/s00092-020-4050-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00092-020-4050-8